Submissions

Login or Register to make a submission.

Author Guidelines

1. Manuscript Submission Overview

Scope and Policy

The European Journal of Innovative Medical Research (EURJIMR) publishes high-quality original studies, systematic reviews, meta-analyses, case reports, surgical techniques, and clinical images in all fields of medicine and healthcare innovation. Submissions must be original, not published previously, and not under consideration elsewhere.

Submission System

Manuscripts must be submitted electronically through the online submission platform (www.ejimr.org). The corresponding author is responsible for ensuring that all co-authors have approved the final manuscript.

The template files for the main articles types are reachable from these links: Original Article Template, Narrative Review Template, Case Report Template, Title Page Template

Consent Forms for Case Reports are reachable from these links: Case Report Consent Form (English Version), Case Report Consent Form (Turkish Translation) 

Manuscript Types

  • Original Research Articles: Full reports of novel studies with structured abstract.

  • Review Articles: Comprehensive and critical analyses of current knowledge.

  • Case Reports: Reports of rare or instructive clinical cases.

  • Short Communications / Letters: Brief reports, comments, or technical notes.

  • Surgical Techniques: Detailed descriptions of innovative procedures.

  • Original Clinical Images: Concise image-based case presentations.


2. Manuscript Preparation

Language and Format

Manuscripts must be written in clear English. Turkish submissions are accepted if accompanied by an English abstract.
Text must be prepared in Microsoft Word, Times New Roman font, 11-point, 1.5-line spacing, justified.
Figures must be high-resolution (≥300 dpi) in JPG, JPEG, or PNG format.

Article Structure

Front Matter: Title, author list, affiliations, abstract, and keywords.
Main Text: Introduction, Materials and Methods, Results, Discussion, Conclusions.
Back Matter: Author Contributions, Funding, Institutional Review Board Statement, Informed Consent, Data Availability, Acknowledgments, Conflicts of Interest, References.

Title Page

Authors are required to prepare the title page in accordance with the journal’s standardized template. Please download and use the official title page template when submitting to the European Journal of Innovative Medical Research (EURJIMR).

Include:

  • Article type and title (concise and descriptive).

  • Full author names, institutional affiliations, and ORCID iDs.

  • Corresponding author’s contact information (email, phone, address).

  • Ethics approval (committee name, approval number, and date).

  • Conflict of interest, funding statement, and author contribution statement.

  • Disclosure of prior presentation or preprint (if applicable).


3. Abstract and Keywords

  • Structured Abstract (for research): Background, Methods, Results, Conclusion.

  • Unstructured Abstract (for reviews, case reports): single paragraph, ≤250 words.

  • Keywords: 3–6 terms from Medical Subject Headings (MeSH).


4. References – AMA 11th Edition

EURJIMR follows the American Medical Association (AMA) 11th Edition style.

  • References are numbered consecutively in the order cited.

  • Use superscript Arabic numerals outside punctuation (e.g., “surgery improves outcomes.¹”).

  • List all references numerically at the end of the text.

Examples:

Journal Article:

  1. Smith TJ, Jones ML. Outcomes of laparoscopic hernia repair in elderly patients. Eur J Innov Med Res. 2025;1(2):45-53. doi:10.xxxx/eurjimr.2025.002

Book:
2. Ravel R. Clinical Laboratory Medicine. 4th ed. Chicago, IL: Yearbook Medical Publishers; 1984:265-281.

Book Chapter:
3. Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press; 1995:465-478.

Online Source:
4. World Health Organization. Gender and health. Updated May 8, 2023. Accessed June 15, 2025. https://www.who.int/health-topics/gender

Reference management tools (EndNote, Zotero, Mendeley) may use the “AMA 11th” style file.


5. Ethical Principles

Human and Animal Research

  • All studies involving humans must comply with the Declaration of Helsinki (2013).

  • Animal research must follow ARRIVE and ICLAS guidelines.

  • Ethics approval (committee name, approval number, date) must be stated in Methods and on the Title Page.

  • Case reports require written informed consent from the patient or guardian.

Clinical Trials

Clinical trials must be registered in a recognized database (e.g., ClinicalTrials.gov or EU Clinical Trials Register), with the registration number included in the manuscript.

Data and Image Integrity

Image manipulation that alters data is prohibited. Authors may be required to submit original uncropped images or raw datasets upon request.


6. Authorship and Contributions

Authorship must meet ICMJE criteria:

  1. Substantial contribution to conception, design, data acquisition, or analysis.

  2. Drafting or critically revising the work.

  3. Final approval of the version to be published.

  4. Agreement to be accountable for all aspects of the work.

Author contributions must be described using the CRediT taxonomy, e.g.:

Conceptualization: M.B.T.; Methodology: M.B.T. and J.S.; Writing – Original Draft: M.B.T.; Writing – Review & Editing: J.S.

Requests to add or remove authors after submission require written approval from all authors.


7. Conflict of Interest and Funding

All potential conflicts (financial or personal) must be disclosed in a Conflicts of Interest section.
If none exist, include:

The authors declare no conflicts of interest.

Funding details should be stated clearly:

This research was funded by [Funder Name, Grant Number].
or
This research received no external funding.


8. Research Data and Supplementary Material

Authors are encouraged to make datasets, code, and supplementary materials publicly available in trusted repositories (e.g., Zenodo, Figshare, TÜBİTAK Aperta).
A Data Availability Statement is required in all manuscripts. Examples:

  • Data are available in [repository name, DOI].

  • Data available on request due to ethical restrictions.


9. Peer Review Process

All submissions undergo double-blind peer review by at least two experts.
Decisions: Accept, Minor Revision, Major Revision, or Reject.
Authors must provide detailed, point-by-point responses to reviewer comments.


10. Publication Ethics

EURJIMR adheres to COPE and ICMJE guidelines.

  • Duplicate submission, plagiarism, or fabricated data will result in rejection or retraction.

  • All manuscripts are screened with plagiarism detection software.

  • Authors must promptly notify the journal of significant errors after publication.

  • Dual-use or unethical research will not be accepted.


11. Editorial Independence

Editorial decisions are made solely based on scientific merit, originality, and ethical compliance. Neither sponsors nor publishers influence acceptance decisions.


12. Submission Checklist

Before submission, confirm that:

  • The manuscript is original and not under review elsewhere.

  • All authors meet ICMJE authorship criteria.

  • Ethical approval and consent statements are included.

  • Figures and tables are high-quality and properly numbered.

  • References follow AMA 11th style.

  • The cover letter explains the study’s novelty and significance.


Contact Information
European Journal of Innovative Medical Research (EURJIMR)
Published by Annika Publishing House, Türkiye
Email: editorial@eurjimr.com | Website: www.eurjimr.com
ISSN (pending) | CC BY-NC 4.0 License

Submission Preparation Checklist

All submissions must meet the following requirements.

  • This submission meets the requirements outlined in the Author Guidelines.
  • This work is original, has not been previously published, and is not under consideration elsewhere.

  • All authors have approved the submitted version and agree with its submission.

  • All references have been checked for accuracy and formatted according to the AMA 11th Edition.

  • All figures, tables, and supplementary materials are properly numbered, labeled, and cited.

  • Permission has been obtained for all images, datasets, and third-party materials included in this submission.

  • Ethical approval, informed consent, and conflict of interest statements are included where applicable.

Original Articles

Original Articles in this journal are full-length research manuscripts presenting novel findings with methodological rigor and clear scientific contribution. Submissions must include a structured abstract, an introduction with relevant background, detailed methods that allow reproducibility, results supported by appropriate statistical analysis, and a critical discussion of the findings within the context of the current literature. Only original, unpublished work that is not under consideration elsewhere will be considered. All submissions undergo double-blind peer review.

Narrative Review Articles

Review Articles provide a comprehensive, balanced, and up-to-date synthesis of the current evidence on a clearly defined topic. Submissions should critically evaluate the literature rather than merely summarize it, identify gaps in knowledge, and highlight implications for clinical practice and future research. Authors are expected to demonstrate methodological transparency in their literature search and selection strategy. Narrative, systematic, and scoping reviews are accepted when they follow appropriate scholarly standards. All submissions undergo peer review.

Case Reports

Case Reports present rare, unusual, or illustrative clinical cases that offer meaningful educational value for clinical practice. Submissions should clearly describe the patient presentation, diagnostic work-up, management, and outcome, and include a concise discussion that highlights the clinical lessons learned and their relevance to current knowledge. Cases may be accepted, whether novel or typical, provided they contribute to clinical understanding or enhance decision-making. Written informed consent from the patient (or legal guardian) is required. All submissions undergo peer review.

Letter to the Editor

Letters to the Editor provide brief scholarly commentary relevant to previously published articles, current issues in the field, or emerging clinical or research observations. Submissions should be concise, well-reasoned, and supported by appropriate evidence when applicable. Letters may critique, clarify, or expand upon published work, or present short clinical insights of educational value. When a letter comments on a published article, the original authors may be invited to respond. All submissions are subject to editorial review and may undergo peer review at the discretion of the Editorial Board.

Privacy Statement

The European Journal of Innovative Medical Research (EURJIMR) is committed to protecting the privacy and personal data of all users, authors, reviewers, and readers. This Privacy Statement explains how the journal collects, uses, and safeguards personal information obtained through its website and submission system.

1. Information We Collect

When users register on our website, submit manuscripts, or act as reviewers, we may collect the following types of information:

  • Personal details such as name, institutional affiliation, email address, and ORCID iD.

  • Contact information for communication regarding submissions or editorial processes.

  • Metadata associated with submitted manuscripts (e.g., co-author names, keywords, abstracts).

  • Technical information such as IP addresses, browser type, and access logs, used for security and statistical purposes.

2. Purpose of Data Collection

Personal information is used exclusively for:

  • Managing submissions, peer review, and editorial correspondence.

  • Publication metadata (author names, affiliations, and ORCID identifiers).

  • Statistical analysis to improve the journal’s editorial operations.

  • Notification of journal updates, calls for papers, and publication announcements (only when users have opted in).

EURJIMR does not sell, rent, or otherwise distribute personal data to third parties.

3. Data Retention and Security

All user and submission data are stored securely on protected servers managed by the publisher, Annika Publishing House, located in Türkiye. Access is restricted to authorized editorial staff only.
Data are retained for as long as necessary to maintain the scholarly record and comply with indexing or archiving requirements.

4. Cookies and Analytics

The journal website uses cookies to improve user experience, enable login sessions, and analyze site traffic. Users may disable cookies in their browser settings, though some functions may be limited.

5. Third-Party Services

EURJIMR may use third-party tools (e.g., Crossref, Google Analytics, ORCID, or DOI registration services) to support publication management. These services operate under their own privacy policies and compliance frameworks.

6. User Rights

Users may request:

  • Access to their personal data,

  • Correction of inaccurate information, or

  • Deletion of their user account and associated data, unless retention is required by law or for maintaining the publication record.

To exercise these rights, users may contact the editorial office at privacy@eurjimr.org.

7. Policy Updates

This Privacy Statement may be revised periodically to comply with evolving data protection laws and best practices. Any updates will be published on this page, and continued use of the website will constitute acceptance of the revised policy.


Contact Information
European Journal of Innovative Medical Research (EURJIMR)
Published by Annika Publishing House
Email: editorial@eurjimr.com | Website: www.eurjimr.com